4/20
04:05 pm
eq
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event
Low
Report
Equillium to Participate in Oppenheimer’s 2026 Innovation on the Island Event
4/17
02:18 pm
eq
Equillium (EQ) had its "buy" rating reaffirmed by Roth Mkm. They now have a $12.00 price target on the stock.
Low
Report
Equillium (EQ) had its "buy" rating reaffirmed by Roth Mkm. They now have a $12.00 price target on the stock.
4/16
10:00 am
eq
Equillium (EQ) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $6.00 price target on the stock.
Medium
Report
Equillium (EQ) is now covered by B. Riley Financial, Inc.. They set a "buy" rating and a $6.00 price target on the stock.
4/13
06:07 pm
eq
Equillium (EQ) was given a new $6.00 price target by Raymond James Financial, Inc.. They now have a "strong-buy" rating on the stock.
Medium
Report
Equillium (EQ) was given a new $6.00 price target by Raymond James Financial, Inc.. They now have a "strong-buy" rating on the stock.
4/8
08:30 am
eq
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
Medium
Report
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
4/7
09:00 am
eq
Equillium (EQ) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
Medium
Report
Equillium (EQ) is now covered by Cantor Fitzgerald. They set an "overweight" rating and a $10.00 price target on the stock.
4/2
04:05 pm
eq
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3/26
03:31 am
eq
Equillium GAAP EPS of -$0.04 beats by $0.02, revenue of $0M [Seeking Alpha]
Low
Report
Equillium GAAP EPS of -$0.04 beats by $0.02, revenue of $0M [Seeking Alpha]
3/25
04:17 pm
eq
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights [Yahoo! Finance]
Low
Report
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights [Yahoo! Finance]
3/25
04:05 pm
eq
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
Neutral
Report
Equillium Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate and Clinical Highlights
3/24
05:57 pm
eq
Here's What Roth Capital Thinks of Equillium (EQ) Stock [Yahoo! Finance]
Medium
Report
Here's What Roth Capital Thinks of Equillium (EQ) Stock [Yahoo! Finance]
3/18
08:30 am
eq
Equillium to Participate in the 38th Annual Roth Conference
Low
Report
Equillium to Participate in the 38th Annual Roth Conference
3/13
08:36 am
eq
Equillium Announces $35 Million Financing with RA Capital Management [Yahoo! Finance]
Medium
Report
Equillium Announces $35 Million Financing with RA Capital Management [Yahoo! Finance]
3/13
08:00 am
eq
Equillium Announces $35 Million Financing with RA Capital Management
High
Report
Equillium Announces $35 Million Financing with RA Capital Management
2/28
05:57 am
eq
Equillium (EQ) was upgraded by Zacks Research to "hold".
Medium
Report
Equillium (EQ) was upgraded by Zacks Research to "hold".
2/25
08:48 am
eq
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference [Yahoo! Finance]
Medium
Report
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference [Yahoo! Finance]
2/25
08:30 am
eq
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference
Medium
Report
Equillium to Participate in the Leerink Partners 2026 Global Healthcare Conference
2/25
08:00 am
eq
Equillium (EQ) is now covered by Stifel Nicolaus. They set a "buy" rating and a $5.00 price target on the stock.
Medium
Report
Equillium (EQ) is now covered by Stifel Nicolaus. They set a "buy" rating and a $5.00 price target on the stock.
2/2
04:05 pm
eq
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Neutral
Report
Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)